Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial

Peer Review reports

Original Submission
26 Oct 2022	Submitted	Original manuscript
17 Nov 2022	Reviewed	Reviewer Report - Alexander Gough
12 May 2023	Reviewed	Reviewer Report - Research Square Reviewer 1
12 Jun 2023	Author responded	Author comments - Jingyuan Li
Resubmission - Version 2
12 Jun 2023	Submitted	Manuscript version 2
Publishing
13 Jun 2023	Editorially accepted
19 Jun 2023	Article published	10.1186/s13063-023-07461-3

Back to article page